Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA News & Analysis

Here you will find all the research and views on CIPLA that we post on Equitymaster. Use the tools to customize the results to suit your preference!


















Authors
 

CIPLA 2023-24 Annual Report Analysis

Mar 31, 2024 | Updated on Nov 22, 2024

Here's an analysis of the annual report of CIPLA for 2023-24. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Fact Sheet, CIPLA Financial Results - Equitymaster

Nov 22, 2024 | Updated on Nov 22, 2024

Check out CIPLA fact sheet and CIPLA financial results online at Equitymaster.

CIPLA Quarterly Results - Equitymaster

Nov 21, 2024 | Updated on Nov 21, 2024

Check out latest CIPLA Quarterly Results online at Equitymaster.

CIPLA Share price, NSE/BSE Forecast News and Quotes| Equitymaster

Nov 21, 2024 | Updated on Nov 21, 2024

CIPLA: Get the latest CIPLA Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com.

Top 5 Indian Stocks which have Consistently Declared Bonus Shares Top 5 Indian Stocks which have Consistently Declared Bonus Shares

Oct 15, 2024

These companies have issued bonus shares the most times. Do you own any?

Top 5 Debt-Free Companies to Watch Out for in 2025 Top 5 Debt-Free Companies to Watch Out for in 2025

Oct 4, 2024

These debt-free giants offer valuable insights into what it takes to succeed without relying on borrowed money.

Which Companies Manufacture Pharma APIs in India? Which Companies Manufacture Pharma APIs in India?

Sep 21, 2024

Active pharmaceutical ingredients (APIs) are the key ingredients in medicines. Here are the top Indian leading manufacturers of API.

Best Pharma Stock: Sun Pharma vs Cipla Best Pharma Stock: Sun Pharma vs Cipla

Jun 13, 2024

The Indian pharmaceutical industry is on its journey to become US$ 130 billion by 2030, and this company stands to benefit the most.

Don't Fall for the Trap in Pharma Stocks Don't Fall for the Trap in Pharma Stocks

Apr 24, 2023

Multiple technical factors indicate that investors should avoid pharma stocks in the current market. More details inside...

Why Cipla Share Price is Falling Why Cipla Share Price is Falling

Mar 2, 2023

One of the best pharma stocks in India, Cipla is starting to show signs of downtrend after a decent rally in early 2023. What next?

Covid 2023 - Who Could be the New Winners and Losers Covid 2023 - Who Could be the New Winners and Losers

Dec 26, 2022

With Covid cases rising in China, stocks specific to covid are reacting both ways. Find out the biggest beneficiaries and the ones to get most affected.

Why Cipla Share Price is Rising Why Cipla Share Price is Rising

Dec 22, 2022

Pharma stocks are in focus amid renewed fears of Covid outbreaks and have rallied between 5-15% in the past couple of days.

Cipla vs Sun Pharma: Which Pharma Stock is Better? Cipla vs Sun Pharma: Which Pharma Stock is Better?

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

5 Stocks to Watch Out for Amid the Omicron Outbreak 5 Stocks to Watch Out for Amid the Omicron Outbreak

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Indian Pharma Companies Riding the Vaccination Wave 5 Indian Pharma Companies Riding the Vaccination Wave

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Cipla Shares Tank Despite Strong Earnings Cipla Shares Tank Despite Strong Earnings

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Cipla's New Covid-19 Drug to Be Sold at Rs 59,750 Per Dose

May 25, 2021

The first batch of Roche's antibody cocktail has been launched in India, with the second batch to be made available by mid-June.


Our Big Prediction

This Could be One of the
Biggest Opportunities for Investors

MARKET STATS